mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.01 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.02 |